Risk factors for drug-induced gingival overgrowth

被引:184
作者
Seymour, RA [1 ]
Ellis, JS [1 ]
Thomason, JM [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Dent, Dept Restorat Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England
关键词
drug-induced gingival overgrowth; risk factors; phenytoin; cyclosporin; calculus channel blocker;
D O I
10.1034/j.1600-051x.2000.027004217.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/Aims: Drug-induced gingival overgrowth remains a significant problem for the periodontologist. Many patients medicated with the drugs implicated in this unwanted effect experience significant, recurrent gingival problems that, require repeated surgical excisions. In this review, we attempt to identify and quantify the Various "risk factors" associated with both the development and expression of the drug-induced gingival changes. Method: The risk factors appraised include age, sex, drug variables, concomitant medication, periodontal variables and genetic factors. Elucidation of such factors may help to identify "at risk patients" and then develop appropriate treatment strategies. Results: Of the factors identified, the only one that can be affected by the periodontologist is the patents' periodontal condition. However, drug variables and concomitant medication do impact upon the expression of gingival overgrowth. Conclusion: The identification of risk factors associated with both the prevalence and severity of drug-induced gingival overgrowth is important for all parties involved with this unwanted effect. Both periodontologist and patient have an important role to play in improving oral hygiene and gingival health. Likewise, there is always an opportunity to establish a close liaison between the patient's physician and the periodontologist to try and identify alternative drug regimens that can help reduce the impact of this unwanted effect.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 68 条
  • [21] MAJOR METABOLITE OF PHENYTOIN (DILANTIN) INDUCES GINGIVAL OVERGROWTH IN CATS
    HASSELL, TM
    PAGE, RC
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 1978, 13 (03) : 280 - 282
  • [22] HASSELL TM, 1981, EPILEPSY ORAL MANIFE
  • [23] GINGIVAL OVERGROWTH IN CYCLOSPORINE-A TREATED MULTIPLE-SCLEROSIS PATIENTS
    HEFTI, AF
    ESHENAUR, AE
    HASSELL, TM
    STONE, C
    [J]. JOURNAL OF PERIODONTOLOGY, 1994, 65 (08) : 744 - 749
  • [24] FACTORS INFLUENCING NIFEDIPINE-INDUCED GINGIVAL OVERGROWTH IN RATS
    ISHIDA, H
    KONDOH, T
    KATAOKA, M
    NISHIKAWA, S
    NAKAGAWA, T
    MORISAKI, I
    KIDO, JI
    OKA, T
    NAGATA, T
    [J]. JOURNAL OF PERIODONTOLOGY, 1995, 66 (05) : 345 - 350
  • [25] KAPUR RN, 1973, DEV MED CHILD NEUROL, V15, P483
  • [26] Karpinia Katherine A., 1996, Pediatric Dentistry, V18, P450
  • [27] Kilpatrick NM, 1997, J HEART LUNG TRANSPL, V16, P1231
  • [28] GINGIVAL HYPERPLASIA IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORINE-A AND CALCIUM-ANTAGONISTS
    KING, GN
    FULLINFAW, R
    HIGGINS, TJ
    WALKER, RG
    FRANCIS, DMA
    WIESENFELD, D
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 1993, 20 (04) : 286 - 293
  • [29] GINGIVAL OVERGROWTH INDUCED BY CYCLOSPORINE A IN RATS
    KITAMURA, K
    MORISAKI, I
    ADACHI, C
    KATO, K
    MIHARA, J
    SOBUE, S
    HAMADA, S
    [J]. ARCHIVES OF ORAL BIOLOGY, 1990, 35 (06) : 483 - 486
  • [30] KLOUDA PT, 1986, TISSUE ANTIGENS, V28, P146